FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS AFTER ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS IN A PATIENT WITH LOW RESTING CD4+CD25+CD127LO T REGULATORY CELLS
NEPHROLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined